Moody Lynn & Lieberson, LLC Novartis Ag Transaction History

Moody Lynn & Lieberson, LLC

  • $1.54 Billion
  • Q3 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Novartis Ag stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 2,289 shares of NVS stock, worth $237,621. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,289
Previous 2,489 8.04%
Holding current value
$237,621
Previous $264,000 0.38%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$106.13 - $120.89 $21,226 - $24,178
-200 Reduced 8.04%
2,289 $263,000
Q2 2023

Jul 27, 2023
SELL
$92.52 - $104.91 $7,124 - $8,078
-77 Reduced 3.0%
2,489 $251,000
Q1 2023

May 02, 2023
SELL
$80.03 - $92.81 $160,060 - $185,620
-2,000 Reduced 43.8%
2,566 $236,000
Q4 2022

Feb 01, 2023
BUY
$75.55 - $92.52 $7,177 - $8,789
95 Added 2.12%
4,566 $414,000
Q3 2022

Oct 26, 2022
SELL
$74.61 - $87.26 $21,114 - $24,694
-283 Reduced 5.95%
4,471 $340,000
Q2 2022

Jul 28, 2022
SELL
$80.52 - $93.75 $64,093 - $74,625
-796 Reduced 14.34%
4,754 $402,000
Q3 2021

Oct 26, 2021
BUY
$81.78 - $95.14 $24,452 - $28,446
299 Added 5.69%
5,550 $454,000
Q2 2021

Jul 28, 2021
BUY
$85.24 - $94.15 $3,665 - $4,048
43 Added 0.83%
5,251 $479,000
Q1 2021

Apr 23, 2021
BUY
$83.5 - $98.47 $56,362 - $66,467
675 Added 14.89%
5,208 $445,000
Q4 2020

Jan 26, 2021
SELL
$78.07 - $94.43 $10,149 - $12,275
-130 Reduced 2.79%
4,533 $428,000
Q3 2020

Oct 28, 2020
BUY
$82.14 - $91.0 $23,409 - $25,935
285 Added 6.51%
4,663 $405,000
Q2 2020

Jul 24, 2020
SELL
$80.93 - $91.1 $10,439 - $11,751
-129 Reduced 2.86%
4,378 $382,000
Q4 2019

Jan 28, 2020
BUY
$84.35 - $95.37 $6,663 - $7,534
79 Added 1.78%
4,507 $427,000
Q3 2019

Oct 28, 2019
BUY
$85.54 - $94.26 $11,120 - $12,253
130 Added 3.02%
4,428 $385,000
Q2 2019

Jul 23, 2019
BUY
$75.4 - $92.8 $13,195 - $16,240
175 Added 4.24%
4,298 $392,000
Q1 2019

Apr 23, 2019
BUY
$75.32 - $86.15 $1,355 - $1,550
18 Added 0.44%
4,123 $396,000
Q4 2018

Jan 29, 2019
BUY
$73.66 - $82.02 $22,466 - $25,016
305 Added 8.03%
4,105 $352,000
Q2 2018

Jul 24, 2018
SELL
$64.91 - $73.36 $92,821 - $104,904
-1,430 Reduced 27.34%
3,800 $287,000
Q1 2018

Apr 27, 2018
BUY
$70.39 - $84.15 $14,078 - $16,830
200 Added 3.98%
5,230 $423,000
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $10,487 - $11,257
145 Added 2.97%
5,030 $461,000
Q3 2017

Nov 06, 2017
BUY
$74.14 - $77.27 $362,173 - $377,463
4,885
4,885 $419,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Moody Lynn & Lieberson, LLC Portfolio

Follow Moody Lynn & Lieberson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email